Augusta University Medical Center moving forward on $150M hospital, medical campus
Monday, April 22, 2019 12:00 AM

Augusta University Medical Center is moving forward with plans to construct a new hospital and medical campus on Interstate 20 in Columbia County, Ga., 13 miles west of downtown Augusta.

AU Medical Center on April 19 filed plans with the state of Georgia for the project as a development of regional impact. Plans call for a medical mixed-use campus consisting of an approximately 600,000-square-foot hospital with associated uses, approximately 125,000 square feet of medical office buildings, and approximately 60,000 square feet of professional, health, and retail uses.

Earlier in April, AU Medical Center filed to rezone the 52-acre site of the proposed medical campus. Check out a site plan here. The project is being designed by Catalyst Design Group of Nashville, Tenn.

Read more...
 
Recro, Teva Extend License and Supply Agreement
Wednesday, April 17, 2019 12:00 AM

CDMO Recro Gainesville will continue to supply Verapamil SR capsules through 2024

Recro Gainesville, the contract development and manufacturing organization (CDMO) division of Recro Pharma, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.
 
Under the terms of the amended agreement, Recro Gainesville will continue to supply Teva with Verapamil SR capsules through 2024 and Teva will continue to be Recro Gainesville’s exclusive U.S. distributor of the product, for which Recro Gainesville is the New Drug Application (NDA) holder. The 2019 Teva agreement provides to Recro Gainesville the same revenue economics as the original agreement, including both manufacturing and profit sharing components. Prior to this amendment, the license and supply agreement with Teva for Verapamil SR was renewable on a year-to-year basis. 

Read more...
 
Georgia Bio CEO: Investment in life sciences has produced 14.9% growth in jobs
Wednesday, April 17, 2019 12:00 AM

Georgia’s life science industry has experienced a 14.9 percent growth in employment during the past decade, according to the results of the 2019 Georgia Life Sciences State of the Industry Report released Wednesday morning.

That was nearly double the growth of life sciences employment nationally – 7.7 percent – over the same decade (2007 to 2017).

“We can attribute this growth to increased investment in research and our academic institutions,” said Maria Thacker-Goethe, president and CEO of Georgia Bio.

Read more...
 
Boehringer Ingelheim, PureTech to Partner on Cancer Immunotherapies
Wednesday, April 17, 2019 12:00 AM

Boehringer Ingelheim plans to develop new immuno-oncology treatments for an undisclosed number of targets using PureTech Health’s lymphatic targeting technology for immune modulation, through a collaboration that PureTech said today could generate for it more than $226 million.

The companies will initially focus on applying PureTech’s internally-developed lymphatic targeting platform to an unspecified Boehringer Ingelheim immuno-oncology candidate for gastrointestinal (GI) cancers that is administered directly to the gut lymphatics, PureTech said.

PureTech specializes in developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis. The company’s platform is designed to harness the gut’s lipid transport mechanisms to enable oral administration and transport of drug candidates directly through the gut-draining lymphatic vasculature, also bypassing first pass metabolism in the liver.

Read more...
 
Gwinnett Chamber Announces New President & CEO
Friday, April 12, 2019 12:00 AM

The Gwinnett Chamber, one of the largest suburban Chambers of Commerce in the nation, recently announced its selection for its new President & CEO, effective July 1.

Following a four-month search process, members of the Gwinnett Chamber board of directors voted in support of appointing Nick Masino, currently Gwinnett Chamber & Partnership Gwinnett’s Chief Economic Development Officer, to take the reins from Dr. Dan Kaufman, who has served in the role since 2013.

“The Gwinnett Chamber of Commerce is pleased and excited to announce the selection of Nick Masino as the new President & CEO of the Chamber to succeed retiring Dr. Dan Kaufman. The Chamber conducted a rigorous search for Dr. Kaufman’s successor, resulting in the interviews of six very capable finalists, with Nick emerging as the unanimous choice of the search committee and the Board of Directors,” said 2019 Gwinnett Chamber Board Chairman Tom Andersen. “Nick brings incredible energy and dynamism to the job, with great experience in having directed economic development for the Chamber through the Partnership Gwinnett initiative for over a decade. He’s well respected, not only in Gwinnett County, but in the entire metropolitan Atlanta region, and, with his experience and skill set, he will clearly be able to hit the ground running in leading the Gwinnett Chamber to new heights. He will continue in the line of extremely talented and effective CEOs for the Gwinnett Chamber.”

Read more...
 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 6 of 49